Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × reparixin × Breast × Clear all

Phase

Status

Withdrawn 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 379 Paclitaxel 368 Cyclophosphamide 338 Docetaxel 314 Capecitabine 197 Doxorubicin 196 Letrozole 181 Tamoxifen 154 Carboplatin 153 Fulvestrant 135 Bevacizumab 128 Anastrozole 120 exemestane 119 Lapatinib 117 Epirubicin 116 Gemcitabine 111 Radiotherapy 106 palbociclib 92 Exercise 85 Fluorouracil 83 Vinorelbine 81 Surveys and Questionnaires 80 pertuzumab 78 Albumin-Bound Paclitaxel 76 Filgrastim 71 130-nm albumin-bound paclitaxel 64 pembrolizumab 62 Magnetic Resonance Spectroscopy 59 Everolimus 59 Cisplatin 59

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02370238 2022-09-16

FRIDA

Dompé Farmaceutici S.p.A

Phase 2 Completed

194 enrolled 19 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡